NEI Research News

The National Eye Institute (NEI) recently launched the first-ever human gene therapy trial for the vision disorder X-linked retinoschisis (XLRS). Researchers are conducting the trial at the National Institutes of Health Clinical Research Center in...

Researchers at the Louisiana State University Neuroscience Center of Excellence have discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

Using high-resolution functional magnetic resonance imaging (fMRI), a team of researchers from Vanderbilt and Boston universities, have discovered that more complex processing occurs in the initial stages of the visual system than previously thought.

Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye’s cornea and could one day be used to repair corneal scarring due to infection or injury.

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse.

People are bad at staying focused. We’ve all had our minds wander when we try to concentrate on a task that requires paying close attention but isn’t all that engaging.

A team of scientists has established that a breakdown in communication between two biochemical pathways in the eye is involved in causing cataracts.

A class of medications long used to curb HIV infection shows promise as a therapy for age-related macular degeneration (AMD), suggest findings from an NIH-funded study.

Newly published research provides the first demonstration of how a genetic mutation associated with a common form of albinism leads to the lack of melanin pigments that characterizes the condition.

A new study finds that in learning a visual task, older people exhibited a surprising degree of plasticity, but had trouble filtering out irrelevant information.